Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Biotechnology Sector (CIX: MSECTOR515)
1,939.78   +2.69 (+0.14%)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Sector News
Stories about Biotechnology Sector
 
< Previous 1 2 3 4 Next >
Week in Review: Hisun-Pfizer and Merck-Simcere JVs Come Into Focus
Today 3:42 EDT
Zhejiang Hisun Pharma contributed 75 drug products to gain 51% control of its JV with Pfizer, while Pfizer added eight drugs; the Merck-Simcere JV is focused onsix cardiovascular drugs, two from... Read More
from ChinaBio® Today
Life Technologies Up 18.5% Since SmarTrend Uptrend Call (LIFE)
May 24, 2013
from Comtex SmarTrend® News Briefs
Commit To Buy Affymax Inc At $1, Earn 45.8% Annualized
May 24, 2013
Investors considering a purchase of Affymax Inc (AFFY) stock, but tentative about paying the going market price of $1.35/share, might benefit from considering selling puts among the alternative... Read More
category Stocks
from Market News Video
Commit To Buy Affymax Inc At $1, Earn 45.8% Annualized
May 24, 2013
Investors considering a purchase of Affymax Inc (AFFY) stock, but tentative about paying the going market price of $1.35/share, might benefit from considering selling puts among the alternative... Read More
category Dividends
from Dividend Channel
Commit To Purchase Sequenom Inc At $2.50, Earn 24.8%
May 24, 2013
Investors eyeing a purchase of Sequenom Inc (SQNM) stock, but cautious about paying the going market price of $3.98/share, might benefit from considering selling puts among the alternative strategies... Read More
category Stocks
from Market News Video
Commit To Purchase Sequenom Inc At $2.50, Earn 24.8%
May 24, 2013
Investors eyeing a purchase of Sequenom Inc (SQNM) stock, but cautious about paying the going market price of $3.98/share, might benefit from considering selling puts among the alternative strategies... Read More
category Dividends
from Dividend Channel
Commit To Buy Neurocrine Biosciences, Inc. At $9, Earn 28.8% Annualized
May 24, 2013
Investors considering a purchase of Neurocrine Biosciences, Inc. (NBIX) stock, but cautious about paying the going market price of $12.91/share, might benefit from considering selling puts among the... Read More
category Stocks
from Market News Video
Commit To Buy Neurocrine Biosciences, Inc. At $9, Earn 28.8% Annualized
May 24, 2013
Investors considering a purchase of Neurocrine Biosciences, Inc. (NBIX) stock, but cautious about paying the going market price of $12.91/share, might benefit from considering selling puts among the... Read More
category Dividends
from Dividend Channel
Mid-Day Market Update: Infoblox Jumps On Upbeat Results, Sears Declines
May 24, 2013
Midway through trading Friday, the Dow traded down 0.20 percent to 15,264.01, while the NASDAQ fell 0.29 percent to 3,449.33. The S&P was also down, declining 0.31 percent to 1,645.38. Top Headline... Read More
category Earnings , Benzinga , Movers , and 17 more.
from Latest Articles from Benzinga.com
Closing Bell for Friday on Wall Street: Markets Open Lower, Fail to Break Out
May 24, 2013
DailyFinance.com : U.S. equity markets opened sharply lower again this morning, but this time reacting to yesterday's comments by Fed Chairman Ben Bernanke that the Fed could slow its bond purchases in... Read More
category goog , anf , crm , and 19 more.
from DailyFinance.com
Downtrend Call Working As XenoPort Stock Falls 18.8% (XNPT)
May 24, 2013
from Comtex SmarTrend® News Briefs
Mid-Morning Market Update: Markets Fall, Pandora Posts Higher Revenue
May 24, 2013
Following the market opening Friday, the Dow traded down 0.26 percent to 15,255.34, while the NASDAQ fell 0.55 percent to 3,444.19. The S&P was also down, declining 0.47 percent to 1,642.82. Top... Read More
category Earnings , Benzinga , Movers , and 16 more.
from Latest Articles from Benzinga.com
Mannkind (MNKD) Cools Down after 2 Day Gains
May 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8368347 for the full story. Read More
from StreetInsider.com News Articles
Uptrend Call Working As Cadence Pharmaceuticals Stock Rises 25.6% (CADX)
May 24, 2013
from Comtex SmarTrend® News Briefs
99.3% Return Seen to Date on SmarTrend Gilead Sciences Call (GILD)
May 24, 2013
from Comtex SmarTrend® News Briefs
Watch for Continued Gains in Shares of Neurocrine Biosciences (NBIX)
May 24, 2013
from Comtex SmarTrend® News Briefs
Sangamo Biosciences (SGMO) gets $6.4 M from CIRM – BUY
May 24, 2013
    Strategic Partnership Award from California Institute for Regenerative Medicine   SGMO receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM)... Read More
category Henry McCusker
from Bio-Wire.Com
This AT&T Announcement Should Attract iPhone Prepaid Customers in Droves
May 24, 2013
Must be nice having people fight over you. Apple (NASDAQ: AAPL ) is used to that, though, but another battle is about to get underway and this time it’s in the prepaid phone market. With the price of... Read More
category S , Rumors , Benzinga , and 8 more.
from Latest Articles from Benzinga.com
Google and Facebook Going to War Over Mapping App
May 24, 2013
A bidding war between Google (NASDAQ: GOOG ) and Facebook (NASDAQ: FB ) may be about to erupt, according to Bloomberg . The object of the conflict is Waze, a smartphone-mapping app with unique social... Read More
category Benzinga , Movers , FB , and 15 more.
from Latest Articles from Benzinga.com
UPDATE: Deutsche Bank Initiates Coverage on Alnylam Pharmaceuticals with Buy Rating, $40 PT on Significant Long-Term Value Potential
May 24, 2013
In a report published Friday, Deutsche Bank analyst Alethia Young initiated coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY ) with a Buy rating and $40.00 price target. In the report, Young noted,... Read More
category Deutsche Bank , Benzinga , ALNY , and 3 more.
from Latest Articles from Benzinga.com
Benzinga's Top Initiations
May 24, 2013
Deutsche Bank initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ: ALNY ) with a “buy” rating. The target price for Alnylam Pharmaceuticals is set to $40. Alnylam's stock closed at $28.06... Read More
category Benzinga , CACC , Initiation , and 5 more.
from Latest Articles from Benzinga.com
Bull’s Eye Report: Amgen (AMGN)
May 24, 2013
 Read More
category NASDAQ:AMGN
from InvestorPlace - Latest Headlines
Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy
May 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8367968 for the full story. Read More
from StreetInsider.com News Articles
3SBio’s Shareholders Approve Go-Private Transaction
May 24, 2013
SBio Inc. will go private. A full 87% of company's shareholders voted in favor of the $16.70 per ADS amended offer. The apparent unanimity is far different that the situation one month ago. At that... Read More
from ChinaBio® Today
Sangamo BioSciences Receives $6.4M Strategic Partnership Award from CIRM
May 24, 2013
Sangamo BioSciences, Inc. (NASDAQ: SGMO ) announced that the California Institute for Regenerative Medicine (CIRM) has granted the Company a $6.4 million Strategic Partnership Award to develop a... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
2 Stocks to Buy, 2 to Sell in Big Pharma
May 24, 2013
 Read More
category NASDAQ:JAZZ , Stock Picks , NYSE:PFE , and 3 more.
from InvestorPlace - Latest Headlines
3SBio Shareholders Approve Amended Merger Agreement
May 24, 2013
3SBio Inc. (NASDAQ: SSRX ) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced... Read More
category Contracts , Benzinga , Global , and 5 more.
from Latest Articles from Benzinga.com
Sinovac Beijing Obtains Certificate of Good Manufacturing Practices for Pharmaceutical Products
May 24, 2013
Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading provider of biopharmaceutical products in China, announced that Sinovac Beijing, the main operating subsidiary company of Sinovac, obtained the... Read More
category Benzinga , Global , Guidance , and 2 more.
from Latest Articles from Benzinga.com
Astellas, Medivation Announce Submission of Application for Marketing Approval of Enzalutamide in Japan
May 24, 2013
Astellas Pharma (OTC: ALPMY ) and Medivation (NASDAQ: MDVN ) today announced that Astellas has submitted an application for marketing approval of enzalutamide (generic name) to the Ministry of Health, Read More
category Benzinga , Global , Guidance , and 3 more.
from Latest Articles from Benzinga.com
Marvell Jumps After Beating Q1 Estimates; Company Delivers Upbeat Outlook
May 23, 2013
Chip-maker Marvell Technology (NASDAQ: MRVL ) released its fiscal first-quarter earnings results on Thursday after the closing bell. The company reported earnings per share and revenue which was above... Read More
category Earnings , Benzinga , MRVL , and 5 more.
from Latest Articles from Benzinga.com
< Previous 1 2 3 4 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here